Illumina, Inc. (ILMN)
273.04
+7.32
(+2.75%)
USD |
NASDAQ |
Oct 02, 16:00
273.07
+0.03
(+0.01%)
After-Hours: 20:00
Illumina Market Cap : 41.23B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 41.23B |
| October 01, 2026 | 40.12B |
| September 30, 2026 | 41.33B |
| September 29, 2026 | 41.07B |
| September 28, 2026 | 41.06B |
| September 25, 2026 | 40.77B |
| September 24, 2026 | 41.36B |
| September 23, 2026 | 38.56B |
| September 22, 2026 | 37.37B |
| September 21, 2026 | 36.06B |
| September 18, 2026 | 36.18B |
| September 17, 2026 | 37.02B |
| September 16, 2026 | 34.57B |
| September 15, 2026 | 33.57B |
| September 14, 2026 | 31.44B |
| September 11, 2026 | 31.17B |
| September 10, 2026 | 30.39B |
| September 09, 2026 | 30.96B |
| September 08, 2026 | 31.87B |
| September 04, 2026 | 32.95B |
| September 03, 2026 | 33.47B |
| September 02, 2026 | 32.20B |
| September 01, 2026 | 31.28B |
| August 31, 2026 | 32.26B |
| August 28, 2026 | 32.55B |
| Date | Value |
|---|---|
| August 27, 2026 | 34.38B |
| August 26, 2026 | 33.95B |
| August 25, 2026 | 33.97B |
| August 24, 2026 | 33.71B |
| August 21, 2026 | 33.13B |
| August 20, 2026 | 32.20B |
| August 19, 2026 | 30.96B |
| August 18, 2026 | 28.43B |
| August 17, 2026 | 29.16B |
| August 14, 2026 | 28.82B |
| August 13, 2026 | 29.09B |
| August 12, 2026 | 29.13B |
| August 11, 2026 | 29.12B |
| August 10, 2026 | 28.96B |
| August 07, 2026 | 28.38B |
| August 06, 2026 | 29.25B |
| August 05, 2026 | 30.18B |
| August 04, 2026 | 30.65B |
| August 03, 2026 | 29.92B |
| July 31, 2026 | 30.97B |
| July 30, 2026 | 30.97B |
| July 29, 2026 | 29.42B |
| July 28, 2026 | 29.14B |
| July 27, 2026 | 28.80B |
| July 24, 2026 | 29.50B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Thermo Fisher Scientific, Inc. | 242.11B |
| Agilent Technologies, Inc. | 47.31B |
| Danaher Corp. | 150.46B |
| 10X Genomics, Inc. | 12.18B |
| Pacific Biosciences of California, Inc. | 789.46M |
Market Cap Related Metrics
| PE Ratio | 50.89 |
| PS Ratio | 9.339 |
| Price to Book Value | 14.53 |
| Price to Free Cash Flow | 82.15 |
| Price | 273.04 |
| Earnings Yield | 1.97% |
| Operating PE Ratio | 47.01 |
| Normalized PE Ratio | 58.19 |